Abstract
In nuclear medicine all studies are dynamic. This may seem like a controversial statement as most studies performed in nuclear medicine departments consist of a single static scan. However, even in this case, the temporal dimension plays an important role in terms of the time point for the scan after administration of the tracer as well as its length.
This chapter is dedicated to the memory of Prof. Lyn S Pilowsky.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Parameter identifiability means that a change in the parameter values should always lead to a change in the output function [17].
- 2.
Quote usually attributed to George Box.
References
Cunningham VJ, Gunn RN, Matthews JC (2004) Quantification in positron emission tomography for research in pharmacology and drug development. Nucl Med Commun 25:643–646
Laruelle M (2000) The role of model-based methods in the development of single scan techniques. Nucl Med Biol 27:637–642
Carson RE (1991) The development and application of mathematical models in nuclear medicine. J Nucl Med 32:2206–2208
Leenders KL (2003) In: PET pharmacokinetic course manual. Maguire RP, Leenders KL (eds) Chap. 1, University of Groningen, Groningen, The Netherlands and McGill University, Canada
Gunn RN, Gunn SR, Cunningham VJ (2001) Positron emission tomography compartmental models. J Cereb Blood Flow Metab 21:635–652
Arfken G (1985) Mathematical methods for physicists. Academic, San Diego
Press WH, Teukolsky SA, Vetterling WT, Flannery BP (1992) Numerical recipes in C: the art of scientific computing. Cambridge University Press, Cambridge
Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533–1539
Kety SS, Schmidt CF (1948) The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Investig 27:476–483
Kety SS (1951) The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 3:1–41
Renkin EM (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 197:1205–1210
Crone C (1963) The permeability of capillaries in various organs as determined by use of the “indicator diffusion” method. Acta Physiol Scand 58:292–305
Kerwin RW, Pilowsky LS (1995) Traditional receptor theory and its application to neuroreceptor measurements in functional imaging. Eur J Nucl Med 22:699–710
Michaelis L, Menten ML (1913) Die kinetik der invertinwirkung. Biochem Z 49:1333
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–665
Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217–227
Scheibe PO (2003) Identifiability analysis of second-order systems. Nucl Med Biol 30:827–832
Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE (1991) Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11:735–744
Erlandsson K, Bressan RA, Mulligan RS, Gunn RN, Cunningham VJ, Owens J, Wyper D, Ell PJ, Pilowsky LS (2003) Kinetic modelling of [123I]-CNS 1261 – a novel SPET tracer for the NMDA receptor. Nucl Med Biol 30:441–454
Cunningham VJ, Hume SP, Price GR, Ahier RG, Cremer JE, Jones AK (1991) Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J Cereb Blood Flow Metab 11:1–9
Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS (1996) Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 16:42–52
Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153–158
Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6:279–287
Erlandsson K, Sivananthan T, Lui D, Spezzi A, Townsend CE, Mu S, Lucas R, Warrington S, Ell PJ (2005) Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study. Eur J Nucl Med Mol Imaging 32:329–336
Cunningham VJ, Jones T (1993) Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 13:15–23
Gunn RN, Gunn SR, Turkheimer FE, Aston JAD, Cunningham VJ (2002) Positron emission tomography compartmental models: A basis pursuit strategy for kinetic modelling. J Cereb Blood Flow Metab 22:1425–1439
Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ et al (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(–)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740–747
Slifstein M, Laruelle M (2000) Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med 41:2083–2088
Ogden RT (2003) Estimation of kinetic parameters in graphical analysis of PET imaging data. Stat Med 22:3557–3568
Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834–840
Carson RE (2000) PET physiological measurements using constant infusion. Nucl Med Biol 27:657–660
Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC, Herscovitch P (1993) Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 13:24–42
Kawai R, Carson RE, Dunn B, Newman AH, Rice KC, Blasberg RG (1991) Regional brain measurement of Bmax and KD with the opiate antagonist cyclofoxy: equilibrium studies in the conscious rat. J Cereb Blood Flow Metab 11:529–544
Holden JE, Jivan S, Ruth TJ, Doudet DJ (2002) In vivo receptor assay with multiple ligand concentrations: an equilibrium approach. J Cereb Blood Flow Metab 22:1132–1141
Bressan RA, Erlandsson K, Mulligan RS, Gunn RN, Cunningham VJ, Owens J, Cullum ID, Ell PJ, Pilowsky LS (2004) A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123I]CNS 1261. Nucl Med Biol 31:155–164
Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19:716–723
Cunningham VJ (1985) Non-linear regression techniques in data analysis. Med Inform (Lond) 10:137–142
Schwarz G (1978) Estimating the dimension of a model. Ann Statist 6:461–464
Ogden RT, Ojha A, Erlandsson K, Oquendo MA, Mann JJ, Parsey RV (2007) In vivo quantification of serotonin transporters using [11C]DASB and positron emission tomography in humans: modeling considerations. J Cereb Blood Flow Metab 27:205–217
Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NP, Kerwin RW (1992) Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet 340:199–202
Travis MJ, Busatto GF, Pilowsky LS, Mulligan R, Acton PD, Gacinovic S, Mertens J, Terriere D, Costa DC, Ell PJ, Kerwin RW (1998) 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150. Br J Psychiatry 173:236–241
Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW (1997) Limbic selectivity of clozapine. Lancet 350:490–491
Erlandsson K, Bressan RA, Mulligan RS, Ell PJ, Cunningham VJ, Pilowsky LS (2003) Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings. Neuroimage 19:1205–1214
Stone JM, Davis JM, Leucht S, Pilowsky LS (2009) Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs – an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Schizophrenia Bulletin 35:789–797
Ichise M, Meyer JH, Yonekura Y (2001) An introduction to PET and SPECT neuroreceptor quantification models. J Nucl Med 42:755–763
Slifstein M, Laruelle M (2001) Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 28:595–608
Acknowledgments
The author would like to thank Prof. Brian F Hutton (University College London, UK) and Prof. Roger N Gunn (Glaxo Smith Kline, London, UK and University of Oxford, UK) for valuable comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Appendix A – Compartmental Models
Expressions for the impulse response functions for the 1-TC and 2-TC models are derived below. L{·} represents the Laplace transform, Laplace-domain functions are identified with a tilde, and s is a complex Laplace domain variable.
1.1 The 1-TC Model
With initial condition, C T (0)=0:
Impulse response function:
1.2 The 2-TC Model
With initial conditions, C ND (0) = C S (0) = 0:
Find poles:
Partial fraction expansion:
Impulse response function:
Appendix B – Outcome Measures
2.1 Volume of Distribution
For the 1-TC model we obtain:
for the 2-TC model:
and similarly for the 3-TC model:
2.2 Binding Potential
Expressions for calculating BP F from different model parameters can be derived as shown below, using the identities k 3 = k on B avail, k 4 = k off, k 3′ = f ND k 3, k 2′ = f ND k 2, and K 1/k 2 = f p (from f p [C p ] eq = [C F ] eq and K 1[C p ] eq = k 2[C F ] eq ):
Appendix C – Reference Tissue Models
3.1 The Simplified Reference Tissue Model
From (16.25):
Impulse response function:
where δ(t) is the Dirac delta-function.
3.2 The Full Reference Tissue Model
From (16.25) and (16.29):
where
Impulse response function:
Appendix D – Logan Graphical Analysis
4.1 1-TC Model
with C T (0)=0:
4.2 2-TC Model
with C ND (0)=C S (0)=0:
with C S (t)/C T (t)=constant (pseudoequilibrium):
Rights and permissions
Copyright information
© 2010 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Erlandsson, K. (2010). Tracer Kinetic Modeling: Basics and Concepts. In: Khalil, M. (eds) Basic Sciences of Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85962-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-540-85962-8_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-85961-1
Online ISBN: 978-3-540-85962-8
eBook Packages: MedicineMedicine (R0)